NeoGenomics stock rallies to new yearly high with buyer momentum accelerating

Traders Union
All News
Companies
NeoGenomics surges 6.43% today

Highlights

NEO is trading in a strong bullish trend, having surged 23% in the past week to $13.73, now pressing against its 52-week high.
Momentum indicators signal sustained buyer strength and a high probability of continued gains, but current overbought conditions suggest risk of short-term consolidation.
Expected trading range for the coming week is $13.00–$14.60, with immediate downside risk if price falls below $13.00 and strong support near $11.00.

Bullish structure as price holds above key moving averages

NEO ($13.73) is positioned well above the SMA-20 ($10.91), SMA-50 ($9.56), and SMA-200 ($10.05), reflecting a strong short-, medium-, and long-term bullish trend structure. The Ichimoku Kijun at $10.59 is notably below the current price, identifying immediate support. Near-term support is evident at SMA-20 ($10.91) and the Ichimoku Kijun ($10.59), while key support lies at SMA-50 ($9.56). Immediate resistance is indicated by W1 SMA-200 ($12.64) and the recent 52-week high ($13.74), both just above the market.

Overbought momentum as buyers press toward weekly highs

Momentum signals remain firmly bullish, with MACD and ADX on D1 both pointing to continued upside strength. D1 RSI is elevated at 74, and both the Stoch RSI and CCI confirm clear overbought conditions, flagging the risk of short-term pullback or consolidation. BBP shows strong buyer dominance (1.80), supporting the recent rally. AO is neutral, offering no contradiction to the prevailing uptrend. NEO is trading at $13.73, up from $11.13 a week ago—a gain of 23.4%—marking the top of its weekly range after a volatile move (weekly amplitude 18.5%). The tone is bullish with price pressing against weekly highs. In today's session, NEO advanced 6.4%, underscoring continued aggressive buying.

Bullish continuation likely as buy signals align near resistance

For the upcoming week, the expected trading range is $13.00–$14.60, keeping the price well within the upper band of its yearly range between the 52-week low ($4.72) and high ($13.74). There is a very high probability (more than 80%) of further price increase, given the alignment of buy signals across W1 RSI, MA-50, and trend-following D1 indicators. A baseline scenario sees NEO consolidating between near-term support and recent highs. The bullish case envisions a breakout above resistance, confirming fresh multi-year highs. The bearish scenario, though less likely, would require a decline below $13.00, exposing the asset to steeper pullbacks toward support at the $11–$11.50 zone.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Previously it was reported that NeoGenomics was exhibiting stable momentum with a balanced outlook, as analysts highlighted both upside potential and downside risks. The current analysis introduces fresh market signals, suggesting investors should closely watch for any shifts in trend to identify potential breakout or breakdown scenarios.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.